Back to stocks
NEUP

NEUP

Neuphoria Therapeutics Inc.• Healthcare

Institutional holders
19
As of Q3 2026
Total 13F value
$6.3M
Sum of disclosed positions
New positions
4
This quarter
Sold positions
8
This quarter

Top holders

Institutions with disclosed positions in this stock

FundValueShares% PortfolioChange

Lynx1 Capital Management Lp

$3.1M875.3K0.48%Unchanged

Advisorshares Investments Llc

$1.1M312.9K0.14%+23.7%

Vanguard Capital Management Llc

$618K173.5K0.00%Unchanged

Shay Capital Llc

$463K130.0K0.03%-16.6%

Geode Capital Management, Llc

$180K50.6K0.00%+2.3%

Ikarian Capital, Llc

$169K47.4K0.02%Unchanged

Citadel Advisors

$157K44.0K0.00%-39.3%

Vanguard Fiduciary Trust Co

$120K33.8K0.00%Unchanged

Adar1 Capital Management, Llc

$107K30.0K0.00%Unchanged

Jane Street Group, Llc

$65K18.2K0.00%+21.9%

Susquehanna International Group, Llp

$52K14.7K0.00%New Position

Boothbay Fund Management, Llc

$50K14.0K0.00%Unchanged

Gts Securities Llc

$41K11.5K0.00%New Position

Merck & Co., Inc.

$36K10.0K0.00%Unchanged

Ubs Group Ag

$7972240.00%-89.4%

Morgan Stanley

$207580.00%Unchanged

Allworth Financial Lp

$146410.00%—

Fmr Llc

$57160.00%New Position

Barclays Plc

$1130.00%New Position

Explore